Qualification of Drivers; Exemption Applications; Diabetes Mellitus, 75492-75493 [2012-30640]
Download as PDF
75492
Federal Register / Vol. 77, No. 245 / Thursday, December 20, 2012 / Notices
the NPRM, FMCSA proposed revisions
to the standards for mandatory training
requirements for entry-level operators of
CMVs in interstate operations who are
required to possess a CDL. The proposal
would apply to drivers who apply for a
CDL beginning 3 years after a final rule
goes into effect. Following that date,
persons applying for new or upgraded
CDLs would be required to successfully
complete specified minimum classroom
and BTW training from an accredited
institution or program. The FMCSA
proposed that the State driver-licensing
agency would issue a CDL only if the
applicant presented a valid driver
training certificate obtained from an
accredited institution or program. The
Agency indicated the rulemaking would
strengthen the Agency’s ELDT
requirements in response to the 2005 DC
Circuit Court decision.
Since the publication of the NPRM,
the Agency has completed its review of
the public responses to the proposal and
initiated new research concerning driver
training. The Agency has also begun
exploring new alternatives for mining
Motor Carrier Safety Management
Information System (MCMIS) data and
Commercial Driver’s License
Information System (CDLIS) data to
attempt to assess the safety performance
of new CDL holders compared to that of
more experienced CDL holders. In
addition, in response to the public
comments, the Agency has reexamined
the regulatory options presented in the
2007 NPRM, as well as its estimates of
the driver population who would be
subject to the requirements. As a result,
the Agency has concluded that
additional stakeholder input will be
useful in determining the most
appropriate path forward for an ELDT
rulemaking.
Section 32304 of MAP–21 requires
that FMCSA issue final ELDT
regulations by October 1, 2013,
establishing minimum ELDT
requirements for operators of CMVs.
The listening session at the ABA’s
Marketplace will provide an
opportunity for motorcoach operators
and other interested parties to share
with FMCSA their ideas, especially as
they relate to the training needs for
individuals seeking a passenger
endorsement.
tkelley on DSK3SPTVN1PROD with
II. Meeting Participation and
Information FMCSA Seeks From the
Public
The listening session is open to the
public. Speakers’ remarks will be
limited to 5 minutes each. No preregistration is required. The public may
submit material to the FMCSA staff at
VerDate Mar<15>2010
16:07 Dec 19, 2012
Jkt 229001
the session for inclusion in the public
docket, FMCSA–2007–27748.
III. Alternative Media Broadcasts
During and Immediately After the
Listening Session on January 7, 2013
FMCSA will webcast the listening
session on the Internet. The telephone
access number and other information on
how to participate via the Internet will
be posted on the FMCSA Web site at
www.fmcsa.dot.gov/rules-regulations/
topics/hos/HOS-ListeningSessions.aspx.
FMCSA will docket the transcripts of
the webcast and a separate transcription
of the listening session that will be
prepared by an official court reporter.
Issued on: December 12, 2012.
Larry W. Minor,
Associate Administrator for Policy.
comments, go to https://
www.regulations.gov and/or Room
W12–140 on the ground level of the
West Building, 1200 New Jersey Avenue
SE., Washington, DC, between 9 a.m.
and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of DOT’s dockets by
the name of the individual submitting
the comment (or of the person signing
the comment, if submitted on behalf of
an association, business, labor union, or
other entity). You may review DOT’s
Privacy Act Statement for the Federal
Docket Management System (FDMS)
published in the Federal Register on
January 17, 2008 (73 FR 3316), or you
may visit https://edocket.access.gpo.gov/
2008/pdf/E8-785.pdf.
SUMMARY:
Background
On October 18, 2012, FMCSA
published a notice of receipt of Federal
diabetes exemption applications from
16 individuals and requested comments
from the public (77 FR 64181). The
public comment period closed on
November 19, 2012, and one comment
was received.
FMCSA has evaluated the eligibility
of the 16 applicants and determined that
granting the exemptions to these
individuals would achieve a level of
safety equivalent to or greater than the
level that would be achieved by
complying with the current regulation
49 CFR 391.41(b)(3).
Electronic Access
You may see all the comments online
through the Federal Document
Management System (FDMS) at: https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or
Diabetes Mellitus and Driving
Experience of the Applicants
The Agency established the current
requirement for diabetes in 1970
because several risk studies indicated
that drivers with diabetes had a higher
rate of crash involvement than the
general population. The diabetes rule
provides that ‘‘A person is physically
qualified to drive a commercial motor
vehicle if that person has no established
medical history or clinical diagnosis of
diabetes mellitus currently requiring
insulin for control’’ (49 CFR
391.41(b)(3)).
FMCSA established its diabetes
exemption program, based on the
Agency’s July 2000 study entitled ‘‘A
Report to Congress on the Feasibility of
a Program to Qualify Individuals with
Insulin-Treated Diabetes Mellitus to
Operate in Interstate Commerce as
Directed by the Transportation Act for
the 21st Century.’’ The report concluded
that a safe and practicable protocol to
allow some drivers with ITDM to
operate CMVs is feasible. The
September 3, 2003 (68 FR 52441),
Federal Register notice in conjunction
[FR Doc. 2012–30641 Filed 12–19–12; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[FMCSA Docket No. FMCSA–2012–0283]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
AGENCY:
FMCSA announces its
decision to exempt 16 individuals from
its rule prohibiting persons with
insulin-treated diabetes mellitus (ITDM)
from operating commercial motor
vehicles (CMVs) in interstate commerce.
The exemptions will enable these
individuals to operate CMVs in
interstate commerce.
DATES: The exemptions are effective
December 20, 2012. The exemptions
expire on December 20, 2014.
FOR FURTHER INFORMATION CONTACT:
Elaine M. Papp, Chief, Medical
Programs Division, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA, Room
W64–224, Department of
Transportation, 1200 New Jersey
Avenue SE., Washington, DC 20590–
0001. Office hours are from 8:30 a.m. to
5 p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
E:\FR\FM\20DEN1.SGM
20DEN1
Federal Register / Vol. 77, No. 245 / Thursday, December 20, 2012 / Notices
with the November 8, 2005 (70 FR
67777), Federal Register notice provides
the current protocol for allowing such
drivers to operate CMVs in interstate
commerce.
These 16 applicants have had ITDM
over a range of 1 to 13 years. These
applicants report no severe
hypoglycemic reactions resulting in loss
of consciousness or seizure, requiring
the assistance of another person, or
resulting in impaired cognitive function
that occurred without warning
symptoms, in the past 12 months and no
recurrent (2 or more) severe
hypoglycemic episodes in the past 5
years. In each case, an endocrinologist
verified that the driver has
demonstrated a willingness to properly
monitor and manage his/her diabetes
mellitus, received education related to
diabetes management, and is on a stable
insulin regimen. These drivers report no
other disqualifying conditions,
including diabetes-related
complications. Each meets the vision
requirement at 49 CFR 391.41(b)(10).
The qualifications and medical
condition of each applicant were stated
and discussed in detail in the October
18, 2012, Federal Register notice and
they will not be repeated in this notice.
Discussion of Comments
tkelley on DSK3SPTVN1PROD with
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption from
the diabetes requirement in 49 CFR
391.41(b)(3) if the exemption is likely to
achieve an equivalent or greater level of
safety than would be achieved without
the exemption. The exemption allows
the applicants to operate CMVs in
interstate commerce.
To evaluate the effect of these
exemptions on safety, FMCSA
considered medical reports about the
applicants’ ITDM and vision, and
reviewed the treating endocrinologists’
medical opinion related to the ability of
the driver to safely operate a CMV while
using insulin.
Consequently, FMCSA finds that in
each case exempting these applicants
from the diabetes requirement in 49 CFR
391.41(b)(3) is likely to achieve a level
of safety equal to that existing without
the exemption.
16:07 Dec 19, 2012
The terms and conditions of the
exemption will be provided to the
applicants in the exemption document
and they include the following: (1) That
each individual submit a quarterly
monitoring checklist completed by the
treating endocrinologist as well as an
annual checklist with a comprehensive
medical evaluation; (2) that each
individual reports within 2 business
days of occurrence, all episodes of
severe hypoglycemia, significant
complications, or inability to manage
diabetes; also, any involvement in an
accident or any other adverse event in
a CMV or personal vehicle, whether or
not it is related to an episode of
hypoglycemia; (3) that each individual
provide a copy of the ophthalmologist’s
or optometrist’s report to the medical
examiner at the time of the annual
medical examination; and (4) that each
individual provide a copy of the annual
medical certification to the employer for
retention in the driver’s qualification
file, or keep a copy in his/her driver’s
qualification file if he/she is selfemployed. The driver must also have a
copy of the certification when driving,
for presentation to a duly authorized
Federal, State, or local enforcement
official.
Conclusion
FMCSA received one comment in this
proceeding. Mr. Thomas A. Goodman
stated he had met with a dietitian and
surgeon to start the process for bariatric
surgery, joined the ADA, and signed up
for a diabetes program provided by his
health insurer.
VerDate Mar<15>2010
Conditions and Requirements
Jkt 229001
Based upon its evaluation of the 16
exemption applications, FMCSA
exempts James D. Astle (OH), Gregory L.
Faison (MD), Theodore A. Garsombke
(WI), Thomas A. Goodman (PA),
Kenneth M. Hanson (IA), Ronald D.
Johnston (VA), Carl E. McCartney (PA),
Jerry W. McFarland (OR), Fred Nelson,
Jr. (PA), Ricky L. Osterback (WA),
Francis J. Pollock (MA), Dwaine H.
Sandlin (MI), Dan R. Stark (MN), Chad
E. Vanscoy (OH), Gregory C. Watson
(NC), and Bailey G. Zickefoose, Jr. (WV)
from the ITDM requirement in 49 CFR
391.41(b)(3), subject to the conditions
listed under ‘‘Conditions and
Requirements’’ above.
In accordance with 49 U.S.C. 31136(e)
and 31315 each exemption will be valid
for two years unless revoked earlier by
FMCSA. The exemption will be revoked
if the following occurs: (1) The person
fails to comply with the terms and
conditions of the 1/exemption; (2) the
exemption has resulted in a lower level
of safety than was maintained before it
was granted; or (3) continuation of the
exemption would not be consistent with
the goals and objectives of 49 U.S.C.
31136(e) and 31315. If the exemption is
still effective at the end of the 2-year
period, the person may apply to FMCSA
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
75493
for a renewal under procedures in effect
at that time.
Issued on: December 12, 2012.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2012–30640 Filed 12–19–12; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[FMCSA Docket No. FMCSA–2012–0282]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
Federal Motor Carrier Safety
Administration (FMCSA), DOT
ACTION: Notice of final disposition.
AGENCY:
FMCSA announces its
decision to exempt 14 individuals from
its rule prohibiting persons with
insulin-treated diabetes mellitus (ITDM)
from operating commercial motor
vehicles (CMVs) in interstate commerce.
The exemptions will enable these
individuals to operate CMVs in
interstate commerce.
DATES: The exemptions are effective
December 20, 2012. The exemptions
expire on December 20, 2014.
FOR FURTHER INFORMATION CONTACT:
Elaine M. Papp, Chief, Medical
Programs Division, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA, Room
W64–224, Department of
Transportation, 1200 New Jersey
Avenue SE., Washington, DC 20590–
0001. Office hours are from 8:30 a.m. to
5 p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Electronic Access
You may see all the comments online
through the Federal Document
Management System (FDMS) at: https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov and/or Room
W12–140 on the ground level of the
West Building, 1200 New Jersey Avenue
SE., Washington, DC, between 9 a.m.
and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of DOT’s dockets by
the name of the individual submitting
the comment (or of the person signing
the comment, if submitted on behalf of
an association, business, labor union, or
other entity). You may review DOT’s
E:\FR\FM\20DEN1.SGM
20DEN1
Agencies
[Federal Register Volume 77, Number 245 (Thursday, December 20, 2012)]
[Notices]
[Pages 75492-75493]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-30640]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[FMCSA Docket No. FMCSA-2012-0283]
Qualification of Drivers; Exemption Applications; Diabetes
Mellitus
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces its decision to exempt 16 individuals from its
rule prohibiting persons with insulin-treated diabetes mellitus (ITDM)
from operating commercial motor vehicles (CMVs) in interstate commerce.
The exemptions will enable these individuals to operate CMVs in
interstate commerce.
DATES: The exemptions are effective December 20, 2012. The exemptions
expire on December 20, 2014.
FOR FURTHER INFORMATION CONTACT: Elaine M. Papp, Chief, Medical
Programs Division, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, Room
W64-224, Department of Transportation, 1200 New Jersey Avenue SE.,
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m.,
Monday through Friday, except Federal holidays.
SUPPLEMENTARY INFORMATION:
Electronic Access
You may see all the comments online through the Federal Document
Management System (FDMS) at: https://www.regulations.gov.
Docket: For access to the docket to read background documents or
comments, go to https://www.regulations.gov and/or Room W12-140 on the
ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: Anyone may search the electronic form of all comments
received into any of DOT's dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, or other
entity). You may review DOT's Privacy Act Statement for the Federal
Docket Management System (FDMS) published in the Federal Register on
January 17, 2008 (73 FR 3316), or you may visit https://edocket.access.gpo.gov/2008/pdf/E8-785.pdf.
Background
On October 18, 2012, FMCSA published a notice of receipt of Federal
diabetes exemption applications from 16 individuals and requested
comments from the public (77 FR 64181). The public comment period
closed on November 19, 2012, and one comment was received.
FMCSA has evaluated the eligibility of the 16 applicants and
determined that granting the exemptions to these individuals would
achieve a level of safety equivalent to or greater than the level that
would be achieved by complying with the current regulation 49 CFR
391.41(b)(3).
Diabetes Mellitus and Driving Experience of the Applicants
The Agency established the current requirement for diabetes in 1970
because several risk studies indicated that drivers with diabetes had a
higher rate of crash involvement than the general population. The
diabetes rule provides that ``A person is physically qualified to drive
a commercial motor vehicle if that person has no established medical
history or clinical diagnosis of diabetes mellitus currently requiring
insulin for control'' (49 CFR 391.41(b)(3)).
FMCSA established its diabetes exemption program, based on the
Agency's July 2000 study entitled ``A Report to Congress on the
Feasibility of a Program to Qualify Individuals with Insulin-Treated
Diabetes Mellitus to Operate in Interstate Commerce as Directed by the
Transportation Act for the 21st Century.'' The report concluded that a
safe and practicable protocol to allow some drivers with ITDM to
operate CMVs is feasible. The September 3, 2003 (68 FR 52441), Federal
Register notice in conjunction
[[Page 75493]]
with the November 8, 2005 (70 FR 67777), Federal Register notice
provides the current protocol for allowing such drivers to operate CMVs
in interstate commerce.
These 16 applicants have had ITDM over a range of 1 to 13 years.
These applicants report no severe hypoglycemic reactions resulting in
loss of consciousness or seizure, requiring the assistance of another
person, or resulting in impaired cognitive function that occurred
without warning symptoms, in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the past 5 years. In each case,
an endocrinologist verified that the driver has demonstrated a
willingness to properly monitor and manage his/her diabetes mellitus,
received education related to diabetes management, and is on a stable
insulin regimen. These drivers report no other disqualifying
conditions, including diabetes-related complications. Each meets the
vision requirement at 49 CFR 391.41(b)(10).
The qualifications and medical condition of each applicant were
stated and discussed in detail in the October 18, 2012, Federal
Register notice and they will not be repeated in this notice.
Discussion of Comments
FMCSA received one comment in this proceeding. Mr. Thomas A.
Goodman stated he had met with a dietitian and surgeon to start the
process for bariatric surgery, joined the ADA, and signed up for a
diabetes program provided by his health insurer.
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the diabetes requirement in 49 CFR 391.41(b)(3) if the exemption
is likely to achieve an equivalent or greater level of safety than
would be achieved without the exemption. The exemption allows the
applicants to operate CMVs in interstate commerce.
To evaluate the effect of these exemptions on safety, FMCSA
considered medical reports about the applicants' ITDM and vision, and
reviewed the treating endocrinologists' medical opinion related to the
ability of the driver to safely operate a CMV while using insulin.
Consequently, FMCSA finds that in each case exempting these
applicants from the diabetes requirement in 49 CFR 391.41(b)(3) is
likely to achieve a level of safety equal to that existing without the
exemption.
Conditions and Requirements
The terms and conditions of the exemption will be provided to the
applicants in the exemption document and they include the following:
(1) That each individual submit a quarterly monitoring checklist
completed by the treating endocrinologist as well as an annual
checklist with a comprehensive medical evaluation; (2) that each
individual reports within 2 business days of occurrence, all episodes
of severe hypoglycemia, significant complications, or inability to
manage diabetes; also, any involvement in an accident or any other
adverse event in a CMV or personal vehicle, whether or not it is
related to an episode of hypoglycemia; (3) that each individual provide
a copy of the ophthalmologist's or optometrist's report to the medical
examiner at the time of the annual medical examination; and (4) that
each individual provide a copy of the annual medical certification to
the employer for retention in the driver's qualification file, or keep
a copy in his/her driver's qualification file if he/she is self-
employed. The driver must also have a copy of the certification when
driving, for presentation to a duly authorized Federal, State, or local
enforcement official.
Conclusion
Based upon its evaluation of the 16 exemption applications, FMCSA
exempts James D. Astle (OH), Gregory L. Faison (MD), Theodore A.
Garsombke (WI), Thomas A. Goodman (PA), Kenneth M. Hanson (IA), Ronald
D. Johnston (VA), Carl E. McCartney (PA), Jerry W. McFarland (OR), Fred
Nelson, Jr. (PA), Ricky L. Osterback (WA), Francis J. Pollock (MA),
Dwaine H. Sandlin (MI), Dan R. Stark (MN), Chad E. Vanscoy (OH),
Gregory C. Watson (NC), and Bailey G. Zickefoose, Jr. (WV) from the
ITDM requirement in 49 CFR 391.41(b)(3), subject to the conditions
listed under ``Conditions and Requirements'' above.
In accordance with 49 U.S.C. 31136(e) and 31315 each exemption will
be valid for two years unless revoked earlier by FMCSA. The exemption
will be revoked if the following occurs: (1) The person fails to comply
with the terms and conditions of the 1/exemption; (2) the exemption has
resulted in a lower level of safety than was maintained before it was
granted; or (3) continuation of the exemption would not be consistent
with the goals and objectives of 49 U.S.C. 31136(e) and 31315. If the
exemption is still effective at the end of the 2-year period, the
person may apply to FMCSA for a renewal under procedures in effect at
that time.
Issued on: December 12, 2012.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2012-30640 Filed 12-19-12; 8:45 am]
BILLING CODE 4910-EX-P